ERK and PDE4 cooperate to induce RAF isoform switching in melanoma

Nature Structural and Molecular Biology

Volumn 18, Issue 5, 2011, Pages 584-591

  Marquette, Amélie ^a,b   André, Jocelyne ^a,b   Bagot, Martine ^a,b   Bensussan, Armand ^a,b   Dumaz, Nicolas ^a,b  

^a SAINT LOUIS HOSPITAL   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; B RAF KINASE; CASPASE 3; CASPASE 7; CYCLIC AMP; CYCLIC AMP PHOSPHODIESTERASE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; ISOPROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PHOSPHODIESTERASE 4A; PHOSPHODIESTERASE 4B; PHOSPHODIESTERASE 4D; PHOSPHODIESTERASE IV; PROTEIN NRAS; RAF PROTEIN; RAS PROTEIN; SERINE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL TRANSFORMATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE MUTATION; HUMAN; HUMAN CELL; MELANOCYTE; MELANOMA; MELANOMA CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; CELL DIFFERENTIATION; CELL LINE, TUMOR; CYCLIC AMP; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 4; DOWN-REGULATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; MELANOCYTES; MELANOMA; MICE; PHOSPHORYLATION; PROTEIN ISOFORMS; PROTO-ONCOGENE PROTEINS B-RAF; RAF KINASES; RAS PROTEINS; SIGNAL TRANSDUCTION;

EID: 79955614956     PISSN: 15459993     EISSN: 15459985     Source Type: Journal    
DOI: 10.1038/nsmb.2022     Document Type: Article

References (50)

1. MacKie, R.M., Hauschild, A. & Eggermont, A.M. Epidemiology of invasive cutaneous melanoma. Ann. Oncol. 20 Suppl 6, vi1-vi7 (2009).
2. Hirobe, T. Role of keratinocyte-derived factors involved in regulating the proliferation and differentiation of mammalian epidermal melanocytes. Pigment Cell Res. 18, 2-12 (2005). (Pubitemid 40170600)
3. Dumaz, N. & Marais, R. Integrating signals between cAMP and the RAS/RAF/MEK/ERK signalling pathways. Based on the anniversary prize of the Gesellschaft fur Biochemie und Molekularbiologie Lecture delivered on 5 July 2003 at the Special FEBS Meeting in Brussels. FEBS J. 272, 3491-3504 (2005). (Pubitemid 41021163)
4. McKay, M.M. & Morrison, D.K. Integrating signals from RTKs to ERK/MAPK. Oncogene 26, 3113-3121 (2007). (Pubitemid 46763008)
5. Karnoub, A.E. & Weinberg, R.A. Ras oncogenes: split personalities. Nat. Rev. Mol. Cell Biol. 9, 517-531 (2008). (Pubitemid 351881844)
6. Wellbrock, C., Karasarides, M. & Marais, R. The RAF proteins take centre stage. Nat. Rev. Mol. Cell Biol. 5, 875-885 (2004). (Pubitemid 39486539)
7. Turjanski, A.G., Vaque, J.P. & Gutkind, J.S. MAP kinases and the control of nuclear events. Oncogene 26, 3240-3253 (2007). (Pubitemid 46763018)
8. Cohen, C. et al. Mitogen-actived protein kinase activation is an early event in melanoma progression. Clin. Cancer Res. 8, 3728-3733 (2002). (Pubitemid 35424762)
9. Satzger, I. et al. Anal mucosal melanoma with KIT-activating mutation and response to imatinib therapy-case report and review of the literature. Dermatology 220, 77-81 (2010).
10. Monsel, G., Ortonne, N., Bagot, M., Bensussan, A. & Dumaz, N. c-Kit mutants require hypoxia-inducible factor 1to transform melanocytes. Oncogene 29, 227-236 (2010).
11. Brose, M.S. et al. BRAF and RAS mutations in human lung cancer and melanoma. Cancer Res. 62, 6997-7000 (2002). (Pubitemid 35424092)
12. Davies, H. et al. Mutations of the BRAF gene in human cancer. Nature 417, 949-954 (2002). (Pubitemid 34716871)
13. Garnett, M.J. & Marais, R. Guilty as charged; B-RAF is a human oncogene. Cancer Cell 6, 313-319 (2004). (Pubitemid 39361432)
14. Wellbrock, C. et al. V599EB-RAF is an oncogene in melanocytes. Cancer Res. 64, 2338-2342 (2004).
15. Dumaz, N. et al. In melanoma, RAS mutations are accompanied by switching signaling from BRAF to CRAF and disrupted cyclic AMP signaling. Cancer Res. 66, 9483-9491 (2006). (Pubitemid 44623646)
16. Lee, H.J., Wall, B. & Chen, S. G-protein-coupled receptors and melanoma. Pigment Cell Melanoma Res. 21, 415-428 (2008). (Pubitemid 351990969)
17. Lin, J.Y. & Fisher, D.E. Melanocyte biology and skin pigmentation. Nature 445, 843-850 (2007).
18. Cheli, Y., Ohanna, M., Ballotti, R. & Bertolotto, C. 15-year quest in search for MITF target genes. Pigment Cell Melanoma Res. 23, 27-40 (2009).
19. Houslay, M.D. & Adams, D.R. PDE4 cAMP phosphodiesterases: modular enzymes that orchestrate signalling cross-talk, desensitization and compartmentalization. Biochem. J. 370, 1-18 (2003). (Pubitemid 36259414)
20. Baillie, G.S., Scott, J.D. & Houslay, M.D. Compartmentalisation of phosphodiesterases and protein kinase A: opposites attract. FEBS Lett. 579, 3264-3270 (2005). (Pubitemid 40804673)
21. Houslay, M.D. Underpinning compartmentalised cAMP signalling through targeted cAMP breakdown. Trends Biochem. Sci. 35, 91-100 (2010).
22. Lugnier, C. Cyclic nucleotide phosphodiesterase (PDE) superfamily: a new target for the development of specific therapeutic agents. Pharmacol. Ther. 109, 366-398 (2006). (Pubitemid 43132818)
23. Conti, M. & Beavo, J. Biochemistry and physiology of cyclic nucleotide phosphodiesterases: essential components in cyclic nucleotide signaling. Annu. Rev. Biochem. 76, 481-511 (2007).
24. Omori, K. & Kotera, J. Overview of PDEs and their regulation. Circ. Res. 100, 309-327 (2007).
25. Buscà, R. et al. Ras mediates the cAMP-dependent activation of extracellular signal-regulated kinases (ERKs) in melanocytes. EMBO J. 19, 2900-2910 (2000). (Pubitemid 30386762)
26. Bennett, D.C., Cooper, P.J. & Hart, I.R. A line of non-tumorigenic mouse melanocytes, syngeneic with the B16 melanoma and requiring a tumour promoter for growth. Int. J. Cancer 39, 414-418 (1987). (Pubitemid 17038200)
27. Shepherd, M. et al. Molecular cloning and subcellular distribution of the novel PDE4B4 cAMP-specific phosphodiesterase isoform. Biochem. J. 370, 429-438 (2003). (Pubitemid 36315131)
28. Lynch, M.J. et al. RNA silencing identifies PDE4D5 as the functionally relevant cAMP phosphodiesterase interacting with beta arrestin to control the protein kinase A/AKAP79-mediated switching of the beta2-adrenergic receptor to activation of ERK in HEK293B2 cells. J. Biol. Chem. 280, 33178-33189 (2005). (Pubitemid 41397113)
29. Wan, P.T. et al. Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF. Cell 116, 855-867 (2004). (Pubitemid 38410730)
30. Montagut, C. et al. Elevated CRAF as a potential mechanism of acquired resistance to BRAF inhibition in melanoma. Cancer Res. 68, 4853-4861 (2008).
31. McKay, M.M., Ritt, D.A. & Morrison, D.K. Signaling dynamics of the KSR1 scaffold complex. Proc. Natl. Acad. Sci. USA 106, 11022-11027 (2009).
32. Brummer, T., Naegele, H., Reth, M. & Misawa, Y. Identification of novel ERK-mediated feedback phosphorylation sites at the C-terminus of B-Raf. Oncogene 22, 8823-8834 (2003). (Pubitemid 38021498)
33. Ritt, D.A., Monson, D.M., Specht, S.I. & Morrison, D.K. Impact of feedback phosphorylation and Raf heterodimerization on normal and mutant B-Raf signaling. Mol. Cell. Biol. 30, 806-819 (2010).
34. Dougherty, M.K. et al. Regulation of Raf-1 by direct feedback phosphorylation. Mol. Cell 17, 215-224 (2005). (Pubitemid 40138617)
35. Hoffmann, R., Baillie, G.S., MacKenzie, S.J., Yarwood, S.J. & Houslay, M.D. The MAP kinase ERK2 inhibits the cyclic AMP-specific phosphodiesterase HSPDE4D3 by phosphorylating it at Ser579. EMBO J. 18, 893-903 (1999). (Pubitemid 29082269)
36. MacKenzie, S.J., Baillie, G.S., McPhee, I., Bolger, G.B. & Houslay, M.D. ERK2 mitogen-activated protein kinase binding, phosphorylation, and regulation of the PDE4D cAMP-specific phosphodiesterases. The involvement of COOH-terminal docking sites and NH2-terminal UCR regions. J. Biol. Chem. 275, 16609-16617 (2000). (Pubitemid 30398887)
37. Baillie, G.S., MacKenzie, S.J., McPhee, I. & Houslay, M.D. Sub-family selective actions in the ability of Erk2 MAP kinase to phosphorylate and regulate the activity of PDE4 cyclic AMP-specific phosphodiesterases. Br. J. Pharmacol. 131, 811-819 (2000).
38. Khaled, M., Levy, C. & Fisher, D.E. Control of melanocyte differentiation by a MITF-PDE4D3 homeostatic circuit. Genes Dev. 24, 2276-2281 (2010).
39. Shepherd, M.C., Baillie, G.S., Stirling, D.I. & Houslay, M.D. Remodelling of the PDE4 cAMP phosphodiesterase isoform profile upon monocyte-macrophage differentiation of human U937 cells. Br. J. Pharmacol. 142, 339-351 (2004). (Pubitemid 38746170)
40. McEwan, D.G. et al. Chemoresistant KM12C colon cancer cells are addicted to low cyclic AMP levels in a phosphodiesterase 4-regulated compartment via effects on phosphoinositide 3-kinase. Cancer Res. 67, 5248-5257 (2007). (Pubitemid 46997263)
41. Moon, E.Y. & Lerner, A. PDE4 inhibitors activate a mitochondrial apoptotic pathway in chronic lymphocytic leukemia cells that is regulated by protein phosphatase 2A. Blood 101, 4122-4130 (2003). (Pubitemid 36857894)
42. Fisher, D.E. et al. Melanoma from bench to bedside: meeting report from the 6th international melanoma congress. Pigment Cell Melanoma Res. 23, 14-26 (2009).
43. Heidorn, S.J. et al. Kinase-dead BRAF and oncogenic RAS cooperate to drive tumor progression through CRAF. Cell 140, 209-221 (2010).
44. Solit, D.B. et al. BRAF mutation predicts sensitivity to MEK inhibition. Nature 439, 358-362 (2006). (Pubitemid 43128863)
45. O'Byrne, P.M. & Gauvreau, G. Phosphodiesterase-4 inhibition in COPD. Lancet 374, 665-667 (2009).
46. Cahill, A.L., Herring, B.E. & Fox, A.P. Stable silencing of SNAP-25 in PC12 cells by RNA interference. BMC Neurosci. 7, 9 (2006).
47. Marais, R., Light, Y., Paterson, H.F., Mason, C.S. & Marshall, C.J. Differential regulation of Raf-1, A-Raf, and B-Raf by oncogenic ras and tyrosine kinases. J. Biol. Chem. 272, 4378-4383 (1997). (Pubitemid 27078513)
48. Huston, E. et al. Molecular cloning and transient expression in COS7 cells of a novel human PDE4B cAMP-specific phosphodiesterase, HSPDE4B3. Biochem. J. 328, 549-558 (1997). (Pubitemid 27515599)
49. Moodie, S.A., Willumsen, B.M., Weber, M.J. & Wolfman, A. Complexes of Ras.GTP with Raf-1 and mitogen-activated protein kinase kinase. Science 260, 1658-1661 (1993). (Pubitemid 23247150)
50. Marchmont, R.J. & Houslay, M.D. Insulin trigger, cyclic AMP-dependent activation and phosphorylation of a plasma membrane cyclic AMP phosphodiesterase. Nature 286, 904-906 (1980). (Pubitemid 10010160)